Boulton M, Young A, Hay J, Armstrong D, Flessner M, Schwartz M, Johnston M
Trauma Research Program, Sunnybrook Health Science Centre, University of Toronto, Ontario, Canada.
Neuropathol Appl Neurobiol. 1996 Aug;22(4):325-33. doi: 10.1111/j.1365-2990.1996.tb01111.x.
We investigated lymphatic drainage pathways of the central nervous system in conscious sheep and quantified the clearance of a cerebrospinal fluid (CSF) tracer into lymph and blood. In the first group of studies, 125I-HSA was injected into the lateral ventricles of the brain or into lumbar CSF and after 6 h, various lymph nodes and tissues were excised and counted for radioactivity. Multiple lymphatic drainage pathways of cranial CSF existed in the head and neck region defined by elevated 125I-HSA in the retropharyngeal/cervical, thymic, pre-auricular and submandibular nodes. Implicated in spinal CSF drainage were mainly the lumbar and intercostal nodes. In a second group of experiments, multiple cervical vessels and the thoracic duct were cannulated and lymph diverted from the animals. Transport of tracer through arachnoid villi was taken from recoveries in venous blood. Following intraventricular administration, the 6 h recoveries of 125I-HSA in the lymph (sum of cervical and thoracic duct) and blood were 8.2% +/- 3.0 and 12.5% +/- 4.5 respectively and at 22 h, 25.1% +/- 6.9 and 20.8% +/- 4.1 respectively. When 125I-HSA was injected into lumbar CSF, the 6 h recoveries of tracer in thoracic duct and blood were 11.6% +/- 2.7 and 16.3% +/- 3.7 respectively. Total lymph and blood recoveries were not significantly different in any experiment. We conclude that the clearance of 125I-HSA from the CSF is almost equally distributed between lymphatic and arachnoid villi pathways.
我们研究了清醒绵羊中枢神经系统的淋巴引流途径,并对脑脊液(CSF)示踪剂向淋巴和血液中的清除进行了定量分析。在第一组研究中,将125I-人血清白蛋白(125I-HSA)注入脑侧脑室或腰段脑脊液中,6小时后,切除各种淋巴结和组织并计数放射性。在头颈部区域存在多条颅部脑脊液的淋巴引流途径,由咽后/颈部、胸腺、耳前和下颌下淋巴结中升高的125I-HSA所确定。参与脊髓脑脊液引流的主要是腰段和肋间淋巴结。在第二组实验中,对多条颈血管和胸导管进行插管,并使淋巴从动物体内分流。示踪剂通过蛛网膜绒毛的转运取自静脉血中的回收率。脑室内给药后,125I-HSA在淋巴(颈淋巴和胸导管之和)和血液中的6小时回收率分别为8.2%±3.0和12.5%±4.5,在22小时时分别为25.1%±6.9和20.8%±4.1。当将125I-HSA注入腰段脑脊液时,示踪剂在胸导管和血液中的6小时回收率分别为11.6%±2.7和16.3%±3.7。在任何实验中,淋巴和血液的总回收率均无显著差异。我们得出结论,125I-HSA从脑脊液中的清除在淋巴和蛛网膜绒毛途径之间几乎平均分布。